Co Diagnostics Common Stock Stock Math Transform Exponential Price Movement
| CODX Stock | USD 3.24 -1.16 -26.36% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Co Diagnostics Common Price Movement is a mathematical transformation function to describe exponentially increasing price patterns.
Co Diagnostics Technical Analysis Modules
Most technical analysis of Co Diagnostics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CODX from various momentum indicators to cycle indicators. When you analyze CODX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Co-Diagnostics, Inc. Common Stock
Co Diagnostics Common is scheduled to announce its earnings next week. The stock is undergoing above-average trading activities.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection andor analysis of nucleic acid molecules in the United States and internationally. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. Co Diagnostics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. A high-level view of Co Diagnostics emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 6.78, P/B of 0.23. Co Diagnostics has a market cap of 9.22 M, P/E of 6.78, ROE of -62.12%. 
Gabriel Shpitalnik ยท Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Co Diagnostics Common Stock is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. CODX (USA Stocks:CODX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Co Diagnostics Common Stock may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
CODX Stock is Curated By:
Gabriel Shpitalnik ยท Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Co Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Co Diagnostics' short interest history, or implied volatility extrapolated from Co Diagnostics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 20 shares | |
 | Dividend Beast Invested over 40 shares | |
 | FinTech Invested over 60 shares | |
 | Impulse Invested over 200 shares | |
 | Driverless Cars Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Advertising Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Cash Cows Invested few shares | |
More Resources for CODX Stock Analysis
A structured review of Co Diagnostics Common often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Co Diagnostics Common Stock Stock in context:Co Diagnostics has a market cap of 9.22 M, operating margin of -48.24%, ROE of -62.12%. Use Trending Equities to explore allocation context. This includes a position in Co Diagnostics Common Stock across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.Analysis related to Co Diagnostics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of Co Diagnostics Common is measured differently than book value, which reflects CODX accounting equity. Co Diagnostics' market capitalization is 9.22 M. A P/B ratio of 0.23 suggests Co Diagnostics trades near or below book value. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Co Diagnostics' intrinsic value and market price are different measures derived from different inputs. For Co Diagnostics, key inputs include a P/E ratio of 6.78, a P/B ratio of 0.23, ROE of -62.12%, and revenue of 3.92 M. Trading price represents the transaction level agreed by market participants.